购物车
- 全部删除
- 您的购物车当前为空
QNZ46 是一种 NR2C/NR2D 选择性 NMDA 受体非竞争性拮抗剂。
为众多的药物研发团队赋能,
让新药发现更简单!
QNZ46 是一种 NR2C/NR2D 选择性 NMDA 受体非竞争性拮抗剂。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 109 | 现货 | |
2 mg | ¥ 152 | 现货 | |
5 mg | ¥ 298 | 现货 | |
10 mg | ¥ 523 | 现货 | |
25 mg | ¥ 987 | 现货 | |
50 mg | ¥ 1,930 | 现货 | |
100 mg | ¥ 2,810 | 现货 | |
200 mg | ¥ 3,930 | 现货 |
产品描述 | QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist. |
激酶实验 | Biochemical filter-binding assays for detection of FGFR phosphorylation activities : Reaction mixtures contains 8 mM Tris-HCl (pH 7.5), 10 mmol/L HEPES, 5 mM dithiothreitol, 10 μM ATP, 0.5 μCi 33P-ATP, 10 mM MnCl2, 150 mM NaCl, 0.01% Triton X-100, 4% dimethyl sulfoxide, 0.05 mg/mL poly(Glu:Tyr) (4:1, average molecular weight of 20–50 kDa), and 7.5, 7.5, and 16 ng of FGFR1, FGFR3, and FGFR4, respectively, and are incubated at room temperature for 30 minutes followed by termination with 10% H3PO4. The reaction mixtures are transferred to 96-well MAFB filter plates that are washed 3 times with 0.5% H3PO4. After air-drying, the plates are read with a Trilux reader. |
分子量 | 443.41 |
分子式 | C24H17N3O6 |
CAS No. | 1237744-13-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 4.43 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.